You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR ELIXOPHYLLIN SR

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ELIXOPHYLLIN SR

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04551170 ↗	Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old	Recruiting	Vanderbilt University Medical Center	Phase 2	2020-07-13	Pseudohypoparathyroidism is a genetic disorder with limited treatment options, characterized by early-onset obesity, short stature and resistance to multiple hormones. This phase 2 clinical trial and open-label extension study will test the efficacy of theophylline, a phosphodiesterase inhibitor, in pseudohypoparathyroidism. We hypothesize that theophylline will cause weight loss, slow the rate of growth plate closure and decrease hormone resistance in children.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ELIXOPHYLLIN SR

Condition Name

Chart
Table

Condition Name for ELIXOPHYLLIN SR
Intervention	Trials
Albright Hereditary Osteodystrophy	1
Pseudohypoparathyroidism	1
Pseudohypoparathyroidism Type 1a	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ELIXOPHYLLIN SR
Intervention	Trials
Pseudopseudohypoparathyroidism	1
Pseudohypoparathyroidism	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ELIXOPHYLLIN SR

Trials by Country

Map
Table

Trials by Country for ELIXOPHYLLIN SR
Location	Trials
United States	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ELIXOPHYLLIN SR
Location	Trials
Tennessee	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ELIXOPHYLLIN SR

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ELIXOPHYLLIN SR
Clinical Trial Phase	Trials
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ELIXOPHYLLIN SR
Clinical Trial Phase	Trials
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ELIXOPHYLLIN SR

Sponsor Name

Chart
Table

Sponsor Name for ELIXOPHYLLIN SR
Sponsor	Trials
Vanderbilt University Medical Center	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ELIXOPHYLLIN SR
Sponsor	Trials
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.